DoP invites applications under PLI scheme to boost Medical Device manufacturing, Details
New Delhi: In order to boost domestic manufacturing and attract large investments in the Medical Device Sector, through a recent notice, the Government of India, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals (DoP) has invited applications under the Production Linked Incentive (PLI) Scheme.
As per the notice, the Department of Pharmaceuticals had released guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices on October 29, 2020. Accordingly, proposals were accepted under the Scheme till November 30, 2020. The applications that were submitted have already been evaluated, and the applicants that were chosen have been informed.
Target Segment-I:-Cancer care/ Radiotherapy Medical Devices
Target Segment-II:- Radiology & Imaging Medical Devices (both lonizing & Non- lonizing Radiation products) and Nuclear Imaging Devices.
Target Segment-III:- Anaesthetics & Cardio-Respiratory Medical Devices including Catheters of Cardio-Respiratory Category & Renal Care Medical Devices
Target Segment-IV:- All Implants including Implantable Electronic Devices
The notice also stated that eligible applicants could only apply online, using the link, https://plimedicaldevices.ifciltd.com/ while the detailed guidelines of the scheme are available at https://plimedicaldevices.ifciltd.com/docs/Guidelines_Medical Devices.pdf
The notice also stated that the deadline for receiving complete applications is July 28, 2021.
The Medical Dialogues team had earlier reported that the Department of Pharmaceuticals had launched a PLI scheme for the promotion of domestic manufacturing of medical devices to ensure a level playing field for the domestic manufacturers with a total financial outlay of Rs 3,420 crore for the period 2020-21 to 2027-28
Further, it was reported that at the inauguration ceremony of India Pharma 2021 & India Medical Devices 2021 organized by FICCI along with the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, and Invest India, Gowda had declared that the Department of Pharmaceuticals launched the Production Linked Incentive Scheme for bulk drugs, with a financial outlay of Rs. 6,940 crores across 53 APIs over 6 years and for Medical Devices, another PLI scheme was announced with an outlay of Rs. 3,420.
